These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 12715144

  • 1. [Monogenic hypertension].
    Bähr V, Oelkers W, Diederich S.
    Med Klin (Munich); 2003 Apr 15; 98(4):208-17. PubMed ID: 12715144
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB, Stewart PM.
    J Hypertens Suppl; 1996 Dec 15; 14(5):S19-24. PubMed ID: 9120678
    [Abstract] [Full Text] [Related]

  • 7. Inherited forms of mineralocorticoid hypertension.
    Hassan-Smith Z, Stewart PM.
    Curr Opin Endocrinol Diabetes Obes; 2011 Jun 15; 18(3):177-85. PubMed ID: 21494136
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mineralocorticoid receptors, salt, and hypertension.
    Funder JW, Krozowski Z, Myles K, Sato A, Sheppard KE, Young M.
    Recent Prog Horm Res; 1997 Jun 15; 52():247-60; discussion 261-2. PubMed ID: 9238855
    [Abstract] [Full Text] [Related]

  • 11. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG.
    Horm Res; 2009 Jun 15; 72(1):1-9. PubMed ID: 19571553
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The ENaC channel as the primary determinant of two human diseases: Liddle syndrome and pseudohypoaldosteronism.
    Schild L.
    Nephrologie; 1996 Jun 15; 17(7):395-400. PubMed ID: 8987044
    [Abstract] [Full Text] [Related]

  • 15. Genetics of hypertensive syndrome.
    Martinez-Aguayo A, Fardella C.
    Horm Res; 2009 Jun 15; 71(5):253-9. PubMed ID: 19339789
    [Abstract] [Full Text] [Related]

  • 16. [Hypertension and mineralocorticoids. Usefulness of renin and aldosterone measurements].
    Fardella CE, Montero J, Mosso L.
    Rev Med Chil; 1999 May 15; 127(5):604-10. PubMed ID: 10451632
    [Abstract] [Full Text] [Related]

  • 17. Heritable forms of hypertension.
    Vehaskari VM.
    Pediatr Nephrol; 2009 Oct 15; 24(10):1929-37. PubMed ID: 17647025
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetics of the renin-angiotensin-aldosterone system in human hypertension.
    Corvol P, Soubrier F, Jeunemaitre X.
    Pathol Biol (Paris); 1997 Mar 15; 45(3):229-39. PubMed ID: 9296068
    [Abstract] [Full Text] [Related]

  • 19. Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I.
    Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP.
    Nat Genet; 1998 Jul 15; 19(3):279-81. PubMed ID: 9662404
    [Abstract] [Full Text] [Related]

  • 20. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, Caprio M, Viengchareun S, Lombès M, Zennaro MC.
    Mol Cell Endocrinol; 2004 Mar 31; 217(1-2):119-25. PubMed ID: 15134810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.